International scheduling Australia's Therapeutic Goods Administration (interim decision, April 2024) and New Zealand's Medsafe (Medicines Classification Committee, June 2025) have moved to schedule BPC-157 as a prescription-only medicine, despite its unavailability through legitimate prescription
It supports: Increased collagen and elastin production Improved skin firmness and texture Enhanced hair growth and scalp health Overall tissue regeneration This makes it a powerful solution for anti-aging, skin rejuvenation, and beauty from within
Which boosts energy more, NAD+ or B12 injections
Platelet-Rich Plasma (PRP): A regenerative therapy using the patients own platelets to stimulate healing and reduce chronic tendon inflammation
Expression of the CT/CGRP gene and its regulation by dibutyryl cyclic adenosine monophosphate in human osteoblastic cells
I'm not going to the FDA going, guys, how do we solve this problem